These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 22384454)
1. Fecal lactoferrin as a noninvasive biomarker in inflammatory bowel diseases. Langhorst J; Boone J Drugs Today (Barc); 2012 Feb; 48(2):149-61. PubMed ID: 22384454 [TBL] [Abstract][Full Text] [Related]
2. [Fecal lactoferrin in identifying and management of inflammatory bowel disease]. Pac-Kozuchowska E; Krawiec P; Mroczkowska-Juchkiewicz A Pol Merkur Lekarski; 2014 Jul; 37(217):61-4. PubMed ID: 25154203 [TBL] [Abstract][Full Text] [Related]
3. The use of fecal calprotectin and lactoferrin in patients with IBD. Review. Stragier E; Van Assche G Acta Gastroenterol Belg; 2013 Sep; 76(3):322-8. PubMed ID: 24261027 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome. Otten CM; Kok L; Witteman BJ; Baumgarten R; Kampman E; Moons KG; de Wit NJ Clin Chem Lab Med; 2008; 46(9):1275-80. PubMed ID: 18597588 [TBL] [Abstract][Full Text] [Related]
5. Calprotectin or Lactoferrin: Do They Help. Wright EK Dig Dis; 2016; 34(1-2):98-104. PubMed ID: 26982329 [TBL] [Abstract][Full Text] [Related]
6. [Fecal Calprotectin in Inflammatory Bowel Disease]. Lee J Korean J Gastroenterol; 2016 May; 67(5):233-7. PubMed ID: 27206433 [TBL] [Abstract][Full Text] [Related]
7. Review of fecal biomarkers in inflammatory bowel disease. Sutherland AD; Gearry RB; Frizelle FA Dis Colon Rectum; 2008 Aug; 51(8):1283-91. PubMed ID: 18543035 [TBL] [Abstract][Full Text] [Related]
8. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108 [TBL] [Abstract][Full Text] [Related]
9. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome. Silberer H; Küppers B; Mickisch O; Baniewicz W; Drescher M; Traber L; Kempf A; Schmidt-Gayk H Clin Lab; 2005; 51(3-4):117-26. PubMed ID: 15819166 [TBL] [Abstract][Full Text] [Related]
10. Diagnostics and prognostics of inflammatory bowel disease with fecal neutrophil-derived biomarkers calprotectin and lactoferrin. Sipponen T Dig Dis; 2013; 31(3-4):336-44. PubMed ID: 24246984 [TBL] [Abstract][Full Text] [Related]
11. Clinical utility of calprotectin and lactoferrin as markers of inflammation in patients with inflammatory bowel disease. Caccaro R; D'Incá R; Sturniolo GC Expert Rev Clin Immunol; 2010 Jul; 6(4):551-8. PubMed ID: 20594128 [TBL] [Abstract][Full Text] [Related]
12. Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease. Joishy M; Davies I; Ahmed M; Wassel J; Davies K; Sayers A; Jenkins H J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):48-54. PubMed ID: 19172123 [TBL] [Abstract][Full Text] [Related]
13. Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease. Kopylov U; Rosenfeld G; Bressler B; Seidman E Inflamm Bowel Dis; 2014 Apr; 20(4):742-56. PubMed ID: 24562174 [TBL] [Abstract][Full Text] [Related]
14. Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease. D'Incà R; Dal Pont E; Di Leo V; Ferronato A; Fries W; Vettorato MG; Martines D; Sturniolo GC Int J Colorectal Dis; 2007 Apr; 22(4):429-37. PubMed ID: 16838143 [TBL] [Abstract][Full Text] [Related]
15. Accuracy of four fecal assays in the diagnosis of colitis. Schoepfer AM; Trummler M; Seeholzer P; Criblez DH; Seibold F Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964 [TBL] [Abstract][Full Text] [Related]
16. Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease. Sipponen T; Kolho KL Scand J Gastroenterol; 2015 Jan; 50(1):74-80. PubMed ID: 25523558 [TBL] [Abstract][Full Text] [Related]
17. [Indicators of inflammatory process in stool in diagnostics and monitoring of inflammatory bowel diseases]. Iwańczak B; Iwańczak F Pol Merkur Lekarski; 2015 Dec; 39(234):389-92. PubMed ID: 26802694 [TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS. Menees SB; Powell C; Kurlander J; Goel A; Chey WD Am J Gastroenterol; 2015 Mar; 110(3):444-54. PubMed ID: 25732419 [TBL] [Abstract][Full Text] [Related]